Free tool
FAERS Monitor: Zunveyl
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 218549 or its brand name (Zunveyl, Benzgalantamine Gluconate). Reports on generic versions are filed under their own applications.
Reports
82
Serious
17
21% of reports
Hospitalization
6
Death reported
1
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- agitation7
- weight decreased7
- confusional state6
- somnolence6
- aggression5
- urinary tract infection5
- fall4
- pruritus4
- sedation4
- tremor4
- decreased appetite3
- gait disturbance3
- hallucination3
- rash3
- scratch3
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2025 | 36 |
| 2026 | 46 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,054,077 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| scratchSignal | 3 | 73.0 | 24.0 | 147 |
| sedationSignal | 4 | 39.2 | 15.1 | 113 |
| aggressionSignal | 5 | 25.6 | 11.0 | 95 |
| agitationSignal | 7 | 24.5 | 12.0 | 135 |
| hallucinationSignal | 3 | 10.2 | 3.4 | 17 |
| confusional stateSignal | 6 | 9.5 | 4.4 | 38 |
| somnolenceSignal | 6 | 7.6 | 3.5 | 29 |
| urinary tract infectionSignal | 5 | 7.5 | 3.2 | 22 |
| weight decreasedSignal | 7 | 6.4 | 3.2 | 27 |
| tremorSignal | 4 | 6.2 | 2.4 | 13 |
| gait disturbanceSignal | 3 | 4.0 | 1.3 | 4 |
| decreased appetite | 3 | 3.3 | 1.1 | 3 |
| fall | 4 | 3.1 | 1.2 | 4 |
| pruritus | 4 | 2.7 | 1.0 | 3 |
| rash | 3 | 1.8 | 0.6 | 0 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.